Neoplasm TransplantationPrognosisLiver TransplantationTransplantation, HomologousKidney TransplantationBone Marrow TransplantationHematopoietic Stem Cell TransplantationHeart TransplantationTransplantation, AutologousLung TransplantationStem Cell TransplantationTransplantation ConditioningOrgan TransplantationGraft SurvivalGraft RejectionPancreas TransplantationIslets of Langerhans TransplantationTissue DonorsTransplantationTransplantation ImmunologyTreatment OutcomeCell TransplantationRetrospective StudiesTransplantation ChimeraImmunosuppressive AgentsGraft vs Host DiseaseTransplantation, IsogeneicTime FactorsLiving DonorsNeoplasmsSurvival AnalysisTransplantation, HeterotopicPancreatic NeoplasmsSurvival RateCord Blood Stem Cell TransplantationFollow-Up StudiesHeart-Lung TransplantationHematologic NeoplasmsTissue and Organ ProcurementTransplantation TolerancePeripheral Blood Stem Cell TransplantationRecurrenceLiver FailureImmunosuppressionPostoperative ComplicationsHistocompatibility TestingFetal Tissue TransplantationLiver NeoplasmsImmunohistochemistryTransplantation, HeterologousNeoplasms, Cystic, Mucinous, and SerousSkin TransplantationWaiting ListsSkin NeoplasmsNeoplasm StagingRisk FactorsMesenchymal Stem Cell TransplantationTumor Markers, BiologicalCorneal TransplantationCombined Modality TherapyHistocompatibilityTacrolimusDisease-Free SurvivalTissue TransplantationWhole-Body IrradiationCyclosporineNeoplasms, Second PrimaryKidney NeoplasmsLeukemiaKaplan-Meier EstimateNeoplasms, Multiple PrimaryCadaverLiver DiseasesLung NeoplasmsProspective StudiesBrain Tissue TransplantationNeoplasm Recurrence, LocalFatal OutcomeFacial TransplantationDonor SelectionLymphomaBiopsyAcute DiseaseMultivariate AnalysisAdenocarcinoma, MucinousOrgan PreservationKidney Failure, ChronicRemission InductionBusulfanDNA, NeoplasmThyroid NeoplasmsHLA AntigensBreast NeoplasmsTransplantsProportional Hazards ModelsCyclophosphamideMyeloproliferative DisordersNeoplasm InvasivenessIncidenceAntineoplastic Combined Chemotherapy Protocols